🦠 Is COVID spiking in your community? Recent data from the Centers for Disease Control and Prevention shows rising COVID-19 levels in wastewater and emergency room visits. The summer surge is concentrated in the South, Southeast, and West Coast regions. View Verily Sightline’s wastewater dashboard to find out if it’s happening near you.
The Rio Grande Valley has one of the highest rates of diabetes in the nation. Superior Health and Verily are bringing patient-centric retinal screenings to this Texas community for high quality imaging data to close gaps in access and care. Watch the full Verily N of 1 episode 👁️ Eye on the Future.
Early detection of diabetic retinopathy can mitigate vision loss by over 90%, but access to screening remains a challenge. Our new study published in JMIR Publications highlights the Verily Numetric Retinal Camera (VNRC) as a potential solution for integrated, primary care-based diabetic retinopathy screening. The results showed 98.5% of images captured by the VNRC were graded as sufficient for clinical interpretation. Learn how the Verily Numetric Retinal Camera's performance and usability could expand access and close gaps in care.
Organizations that generate multi-modal health data and research teams have a shared mission of advancing biomedical science, but siloed systems and cumbersome workflows prevent data access and usage. Read our blog for an approach to connecting and strengthening the biomedical research environment, with the goal of gaining meaningful insights faster and scaling collaboration.
At Verily, we believe that analyzing many different types of health data is key to deeply understanding diseases. Type 2 diabetes is a complex disease, making prevention, diagnosis, and monitoring complicated. New Verily-led research published in Nature Portfolio shows the potential to improve the identification of people at higher risk of developing diabetes by analyzing blood protein profiles. The 4-year study included participants with diverse backgrounds and a wide range of health states from the Project Baseline Health Study. Researchers concluded that understanding diabetes at the molecular level can help refine diagnostic approaches and personalized treatment efforts. Read more detailed methods and findings: https://www.nature.com/articles/s43856-025-00964-x
Supporting better nutrition for individuals managing cardiometabolic conditions is more important — and more challenging — than ever. Explore Verily’s latest Research Insights paper, introducing a novel, evidence-based framework to make it easier: the 3Ps Approach — Practical, Positive, Personalized.
The Verily platform harmonizes and curates complex datasets, enabling advanced analytics and the deployment of healthcare AI models. We’re helping life sciences and pharma companies accelerate therapies and empowering health systems and payers to improve outcomes while reducing costs.
For people living with type 2 diabetes, like Nini, better care requires supporting their lifestyle changes. Watch how Verily is using AI to help clinicians and care teams prioritize higher risk patients and personalize care plans: https://verily.com/n-of-1
🚀 Introducing a new Verily tech blog series giving you an in-depth look at how our product engineers are making healthcare data AI-ready and powering innovations to realize the promise of precision health. Read the inaugural blog post about why and how Verily uses FHIRPath, ensuring clinicians, engineers, product teams, and data informaticists can speak the same healthcare data language.
Happy Fourth of July from all of us at Verily! Our US offices will be closed as we celebrate the 249th birthday of the United States 🇺🇲
